PET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity

Journal of Nuclear Medicine

Volumn 52, Issue 2, 2011, Pages 180-187

  Liao, Chun Ta ^a   Wang, Hung Ming ^a   Huang, Shiang Fu ^a   Chen, I How ^a   Kang, Chung Jan ^a   Lin, Chien Yu ^a   Fan, Kang Hsing ^a   Ng, Shu Hang ^a   Hsueh, Chuen ^a   Lee, Li Yu ^a   Lin, Chih Hung ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

18F FDG PET; Neck; Oral cavity squamous cell carcinoma; Prognosis

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FOLINIC ACID; TEGAFUR;

ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

ADULT; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; DATA INTERPRETATION, STATISTICAL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 79851472429     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.082370     Document Type: Article

References (32)

1. Scully C, Bagan J. Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis. 2009;15:388-399.
2. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006;42:229-239. (Pubitemid 43246755)
3. Ferlito A, Rinaldo A, Robbins KT, et al. Changing concepts in the surgical management of the cervical node metastasis. Oral Oncol. 2003;39:429-435. (Pubitemid 36579109)
4. Iyer SG, Pradhan SA, Pai PS, Patil S. Surgical treatment outcomes of localized squamous carcinoma of buccal mucosa. Head Neck. 2004;26:897-902. (Pubitemid 39299310)
5. Kane SV, Gupta M, Kakade AC, D' Cruz A. Depth of invasion is the most significant histological predictor of subclinical cervical lymph node metastasis in early squamous carcinomas of the oral cavity. Eur J Surg Oncol. 2006;32:795-803. (Pubitemid 44276021)
6. Subapriya R, Thangavelu A, Mathavan B, Ramachandran CR, Nagini S. Assessment of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: a case-control study. Eur J Cancer Prev. 2007;16:251-256. (Pubitemid 46597429)
7. Liao CT, Chang JT, Wang HM, et al. Survival in squamous cell carcinoma of the oral cavity: differences between pT4N0 and other stage IVA categories. Cancer. 2007;110:564-571. (Pubitemid 47106145)
8. Liao CT, Wang HM, Chang JT, et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer. 2007;110:1501-1508. (Pubitemid 47463064)
9. Liao CT, Chang JT, Wang HM, et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when? Cancer. 2008;112:94-103.
10. Liao CT, Chang JT, Wang HM, et al. Analysis of risk factors predictive of local tumor control in oral cavity cancer. Ann Surg Oncol. 2008;15:915-922.
11. Al-Ibraheem A, Buck A, Krause BJ, et al. Clinical applications of FDG PET and PET/CT in head and neck cancer. J Oncol. August 20, 2009 [Epub ahead of print].
12. 18F- fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712-720.
13. 18F-FDG PET in oncology. J Nucl Med. 2008;49:480-508.
14. 18F-FDG PET and CT/MRI. J Clin Oncol. 2006;24:4371-4376.
15. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med. 2005;46:1136-1143.
16. 18F-FDG PET: comparison with head and neck CT/MRI and histopathology. J Nucl Med. 2005;46:775-781.
17. Stuckensen T, Kovács AF, Adams S, et al. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg. 2000;28:319-324. (Pubitemid 32243889)
18. Kim SY, Roh JL, Kim JS, et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol. 2008;34:208-215.
19. Podoloff DA, Ball DW, Ben-Josef E, et al. NCCN task force: clinical utility of PET in a variety of tumor types. J Natl Compr Canc Netw. 2009;7: S1-S26.
20. Podoloff DA, Advani RH, Allred C, et al. NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw. 2007;5:S1-S22.
21. Ung YC, Maziak DE, Vanderveen JA, et al. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst. 2007;99:1753-1767. (Pubitemid 351767209)
22. 18F-fluorodeoxiglucose positron emission tomography for the evaluation of neoadjuvant therapy response in esophageal cancer: systematic review of the literature. Ann Surg. 2009;250:247-254.
23. Schöder H, Fury M, Lee N, et al. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med. 2009;50(suppl):S74-S88.
24. Lai CH, Yen TC, Chang TC. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol. 2007;19:37-41.
25. Juweid ME. Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma. Hematology (Am Soc Hematol Educ Program). 2006;1:259-265, 510-511.
26. 18F-FDG PETas an indicator of therapeutic response in patients in National Cancer Institute Trials. J Nucl Med. 2006;47:1059-1066.
27. 18FDG) uptake measured by positron emission tomography is associated with reduced overall survival in patients with oral squamous cell carcinoma. Oral Oncol. 2009;45:963-967.
28. Ng SH, Chang JT, Chan SC, et al. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1073-1080. (Pubitemid 39050173)
29. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
30. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47:755-762.
31. Wang HM, Wang CS, Chen JS, et al. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002;94:2989-2995.
32. Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999-1004. (Pubitemid 27014483)